Asco 2025 · Posters · Cáncer de Mama · Isabel Blancas, MD, PhD Volver

Cost-effectiveness of HER2/neu 655 genotyping in managing trastuzumab-induced cardiotoxicity risk in HER2-positive breast cancer patients.

Abstract: 543
Poster Bd #: 136
Descargar Poster

Isabel Blancas, MD, PhD

Hospital Universitario Clínico San Cecilio / Medicine Department, Granada University / Instituto de Investigación Biosanitaria de Granada (ibs Granada)

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo